Aptevo Therapeutics Inc (APVO)
0.7400
+0.01
(+2.00%)
USD |
NASDAQ |
May 31, 16:00
0.72
-0.02
(-2.70%)
Pre-Market: 20:00
Aptevo Therapeutics Free Cash Flow: -22.95M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -22.95M |
| December 31, 2023 | -11.73M |
| September 30, 2023 | -12.42M |
| June 30, 2023 | -13.07M |
| March 31, 2023 | -11.34M |
| December 31, 2022 | -21.05M |
| September 30, 2022 | -19.11M |
| June 30, 2022 | -17.46M |
| March 31, 2022 | -19.81M |
| December 31, 2021 | -22.39M |
| September 30, 2021 | -24.52M |
| June 30, 2021 | -26.65M |
| March 31, 2021 | -25.84M |
| December 31, 2020 | -29.32M |
| September 30, 2020 | -28.30M |
| June 30, 2020 | -28.46M |
| March 31, 2020 | -39.71M |
| Date | Value |
|---|---|
| December 31, 2019 | -42.54M |
| September 30, 2019 | -44.78M |
| June 30, 2019 | -48.74M |
| March 31, 2019 | -48.94M |
| December 31, 2018 | -52.40M |
| September 30, 2018 | -60.78M |
| June 30, 2018 | -51.02M |
| March 31, 2018 | -47.60M |
| December 31, 2017 | -42.98M |
| September 30, 2017 | -34.50M |
| June 30, 2017 | -32.84M |
| March 31, 2017 | -37.01M |
| December 31, 2016 | -39.37M |
| September 30, 2016 | -40.33M |
| June 30, 2016 | -50.03M |
| March 31, 2016 | -49.41M |
| December 31, 2015 | -50.29M |
Free Cash Flow Range, Past 5 Years
-48.74M
Minimum
Jun 2019
-11.34M
Maximum
Mar 2023
-25.51M
Average
-23.73M
Median
Free Cash Flow Benchmarks
| Heron Therapeutics Inc | -43.40M |
| Creative Medical Technology Holdings Inc | -5.083M |
| BioSig Technologies Inc | -12.98M |
| Adial Pharmaceuticals Inc | -6.134M |
| IN8bio Inc | -24.06M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.651M |
| Cash from Financing (Quarterly) | -0.003M |
| Free Cash Flow Per Share (Quarterly) | -9.685 |
| Free Cash Flow Yield | -7.94K% |